Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 25;2024(3):omae017.
doi: 10.1093/omcr/omae017. eCollection 2024 Mar.

Isotretinoin-induced myositis

Affiliations
Case Reports

Isotretinoin-induced myositis

Oliver Hague et al. Oxf Med Case Reports. .

Abstract

Retinoid-induced myositis is a phenomenon recognised in multiple case reports. We report a case of isotretinoin-induced myositis in an 18-year-old male patient. This case adds to the published literature as it demonstrates (i) myositis may occur after extended periods of isotretinoin use, (ii) should be considered as a differential diagnosis even when presenting asymmetrically and (iii) can continue to progress clinically and biochemically initially following the suspension of isotretinoin before being effectively treated with corticosteroids.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
CT pelvis demonstrating asymmetric expansion of the right gluteus maximum muscle and associated oedema/stranding in keeping with muscle oedema. Fluid seen tracking into the posterior and lateral compartments of the thigh.
Figure 2
Figure 2
MRI pelvis demonstrating extensive inflammation of the right gluteus maximus with subcutaneous oedema.
Figure 3
Figure 3
CT demonstrating resolution of the right gluteus maximus oedema.

References

    1. Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol 2017;97:173–81. - PubMed
    1. Acar EM, Şaş S, Koçak FA. Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: a cross-sectional study. Arch Rheumatol 2022;37:223–9. - PMC - PubMed
    1. Rivillas JA, Andrade VAS, Hormaza-Jaramillo AA. Myositis induced by isotretinoin: a case report and literature review. Am J Case Rep 2020;21:e917801. - PMC - PubMed
    1. Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther 2017;30:e12483. - PubMed
    1. Marson JW, Baldwin HE. The creatine kinase conundrum: a reappraisal of the association of isotretinoin, creatine kinase, and rhabdomyolysis. Int J Dermatol 2020;59:279–83. - PubMed

Publication types